{"id":30230,"date":"2017-05-22T11:14:40","date_gmt":"2017-05-22T10:14:40","guid":{"rendered":"http:\/\/blog.cofb.cat\/?p=30230"},"modified":"2017-05-22T11:14:40","modified_gmt":"2017-05-22T10:14:40","slug":"formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/","title":{"rendered":"Formacions COFB: quines s\u00f3n les patologies oftalmol\u00f2giques de m\u00e9s prevalen\u00e7a?"},"content":{"rendered":"<p>La prevalen\u00e7a elevada de les patologies oftalmol\u00f2giques i les alteracions oculars genera un problema de salut sociosanitari, tant perqu\u00e8 algunes van lligades a l\u2019envelliment de la poblaci\u00f3 com \u00e9s el cas del glaucoma, de les cataractes i de la degeneraci\u00f3 macular associada a l\u2019edat (DMAE), com un problema de cronicitat o fins i tot de discapacitat o ceguesa. A la farm\u00e0cia, les afeccions oculars s\u00f3n patologies de consulta molt freq\u00fcent.<\/p>\n<figure id=\"attachment_30237\" aria-describedby=\"caption-attachment-30237\" style=\"width: 298px\" class=\"wp-caption alignright\"><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2017\/05\/patologies-oftalmologiques-COFB-2.jpg\"><img fetchpriority=\"high\" decoding=\"async\" class=\" wp-image-30237   \" alt=\"patologies-oftalmologiques-COFB (2)\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2017\/05\/patologies-oftalmologiques-COFB-2.jpg\" width=\"298\" height=\"199\" \/><\/a><figcaption id=\"caption-attachment-30237\" class=\"wp-caption-text\">Pablo Iniesta (Servei d\u2019Oftalmologia de l\u2019Hospital de Manresa), un dels docents del curs<\/figcaption><\/figure>\n<p>El curs \u201c<b>Patologies oftalmol\u00f2giques de m\u00e9s prevalen\u00e7a i altres alteracions oculars<\/b>\u201d que va tenir lloc al COFB els dies 25 i 27 d&#8217;abril, va tractar els diferents tractaments farmacol\u00f2gics de les patologies i les alteracions oculars que sovint s\u00f3n consultades al farmac\u00e8utic i tamb\u00e9 de les mesures de prevenci\u00f3 i de recomanaci\u00f3 per mantenir una bona salut ocular i millorar el consell i l\u2019atenci\u00f3 farmac\u00e8utica oftalmol\u00f2gica.<\/p>\n<p>Ela alumnes assistents van aprendre a recon\u00e8ixer la simptomatologia comuna i diferencial de cada una de les patologies que abordava el curs, els tractaments farmacol\u00f2gics associats i van saber com aconsellar les mesures de prevenci\u00f3 i de recomanaci\u00f3 sanit\u00e0ria i com fer una atenci\u00f3 farmac\u00e8utica correcta i identificar quan cal derivar a l\u2019especialista.<\/p>\n<div class=\"box shadow\">\u201c<b>Una de les funcions m\u00e9s importants del farmac\u00e8utic \u00e9s assegurar que el pacient ha ent\u00e8s perfectament com s\u2019ha d\u2019administrar el col\u00b7liri, perqu\u00e8 \u00e9s fonamental per una correcta adher\u00e8ncia al tractament, aix\u00ed com con\u00e8ixer tots els medicaments que estan contraindicats en aquells pacients que pateixen glaucoma<\/b>\u201d explica <b>Cristina Rodr\u00edguez<\/b>, cap del departament de Formaci\u00f3 del Col\u00b7legi i coordinadora del curs. I afegeix: \u201cUn altre aspecte que s\u2019ha fet pal\u00e8s en el curs \u00e9s que <strong>no s\u2019han d\u2019indicar col\u00b7liris amb corticoides o pomades antibi\u00f2tiques a no ser que es tingui la certesa de la seva indicaci\u00f3, ja que, en cas contrari, poden emmascarar la patologia,\u00a0 dificultant la tasca de l\u2019especialista<\/strong>. Tots aquests aspectes, juntament amb les mesures de prevenci\u00f3 i recomanaci\u00f3 per mantenir una bona salut ocular, ens permetran millorar el consell i l\u2019atenci\u00f3 farmac\u00e8utica oftalmol\u00f2gica\u201d.<\/div>\n<p>El programa del curs va fer un rep\u00e0s als tipus de conjuntivitis (v\u00edriques, bacterianes, al\u00b7l\u00e8rgiques, blefaroconjuntivitis, qu\u00edmiques, irritatives, per malalties sist\u00e8miques, etc.), el glaucoma i degeneraci\u00f3 macular associada a l\u2019edat (DMAE), les catarates, la retinopatia diab\u00e8tica, les alteracions del sistema lacrimal, les malalties de les parpelles i altres alteracions oculars. Tamb\u00e9 es van facilitar \u00a0recomanacions de salut ocular en la inf\u00e0ncia, l\u2019edat adulta i en la gent gran.<\/p>\n<p>El quadre docent el van formar <b>Pablo Infiesta<\/b> del Servei d\u2019Oftalmologia de l\u2019Hospital de Manresa, i<b> Sandra G\u00f3mez <\/b>del Servei d\u00b4Oftalmologia de l\u2019Hospital Universitari Germans Trias i Pujol de Badalona.<\/p>\n<p style=\"text-align: center;\"><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2017\/05\/patologies-oftalmologiques-COFB-1.jpg\"><img decoding=\"async\" class=\"size-large wp-image-30236 aligncenter\" alt=\"patologies-oftalmologiques-COFB (1)\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2017\/05\/patologies-oftalmologiques-COFB-1-1024x534.jpg\" width=\"620\" height=\"323\" \/><\/a><\/p>\n<p>&nbsp;<\/p>\n<p align=\"right\"><b>Amb la col\u00b7laboraci\u00f3 de:<\/b><\/p>\n<p align=\"right\"><a href=\"https:\/\/www.angelini.es\/\" target=\"_blank\" rel=\"noopener\"><img decoding=\"async\" class=\"alignright  wp-image-30235\" alt=\"ANGELINI-logo\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2017\/05\/ANGELINI-logo.jpg\" width=\"116\" height=\"128\" \/><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>La prevalen\u00e7a elevada de les patologies oftalmol\u00f2giques i les alteracions oculars genera un problema de salut sociosanitari, tant perqu\u00e8 algunes van lligades a l\u2019envelliment de la poblaci\u00f3 com \u00e9s el cas del glaucoma, de les cataractes i de la degeneraci\u00f3 macular associada a l\u2019edat (DMAE), com un problema de cronicitat [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":30238,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[57],"tags":[2763,2764,64,2765,2766,2767,69,2228,2768,2769,2770,2771,2772,2773],"class_list":["post-30230","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mon-collegial","tag-alteracions-del-sistema-lacrimal","tag-alteracions-oculars","tag-atencio-farmaceutica","tag-catarates","tag-conjuntivitis","tag-dmae","tag-farmacia-comunitaria","tag-gent-gran","tag-glaucoma","tag-malalties-de-les-parpelles","tag-oftalmologia","tag-patologies-oftalmologiques","tag-retinopatia-diabetica","tag-salut-ocular"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Formacions COFB: quines s\u00f3n les patologies oftalmol\u00f2giques de m\u00e9s prevalen\u00e7a?<\/title>\n<meta name=\"description\" content=\"Formacions COFB: quines s\u00f3n les patologies oftalmol\u00f2giques de m\u00e9s prevalen\u00e7a?\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Formacions COFB: quines s\u00f3n les patologies oftalmol\u00f2giques de m\u00e9s prevalen\u00e7a?\" \/>\n<meta property=\"og:description\" content=\"Formacions COFB: quines s\u00f3n les patologies oftalmol\u00f2giques de m\u00e9s prevalen\u00e7a?\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2017-05-22T10:14:40+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Formacions COFB: quines s\u00f3n les patologies oftalmol\u00f2giques de m\u00e9s prevalen\u00e7a?\",\"datePublished\":\"2017-05-22T10:14:40+00:00\",\"dateModified\":\"2017-05-22T10:14:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/\"},\"wordCount\":522,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"alteracions del sistema lacrimal\",\"alteracions oculars\",\"Atenci\u00f3 farmac\u00e8utica\",\"catarates\",\"conjuntivitis\",\"DMAE\",\"farm\u00e0cia comunit\u00e0ria\",\"gent gran\",\"glaucoma\",\"malalties de les parpelles\",\"oftalmologia\",\"patologies oftalmol\u00f2giques\",\"retinopatia diab\u00e8tica\",\"salut ocular\"],\"articleSection\":[\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/\",\"name\":\"Formacions COFB: quines s\u00f3n les patologies oftalmol\u00f2giques de m\u00e9s prevalen\u00e7a?\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2017-05-22T10:14:40+00:00\",\"dateModified\":\"2017-05-22T10:14:40+00:00\",\"description\":\"Formacions COFB: quines s\u00f3n les patologies oftalmol\u00f2giques de m\u00e9s prevalen\u00e7a?\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Formacions COFB: quines s\u00f3n les patologies oftalmol\u00f2giques de m\u00e9s prevalen\u00e7a?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Formacions COFB: quines s\u00f3n les patologies oftalmol\u00f2giques de m\u00e9s prevalen\u00e7a?","description":"Formacions COFB: quines s\u00f3n les patologies oftalmol\u00f2giques de m\u00e9s prevalen\u00e7a?","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/","og_locale":"ca_ES","og_type":"article","og_title":"Formacions COFB: quines s\u00f3n les patologies oftalmol\u00f2giques de m\u00e9s prevalen\u00e7a?","og_description":"Formacions COFB: quines s\u00f3n les patologies oftalmol\u00f2giques de m\u00e9s prevalen\u00e7a?","og_url":"https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2017-05-22T10:14:40+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"wpAdminCofbOrg","Temps estimat de lectura":"3 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Formacions COFB: quines s\u00f3n les patologies oftalmol\u00f2giques de m\u00e9s prevalen\u00e7a?","datePublished":"2017-05-22T10:14:40+00:00","dateModified":"2017-05-22T10:14:40+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/"},"wordCount":522,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/#primaryimage"},"thumbnailUrl":"","keywords":["alteracions del sistema lacrimal","alteracions oculars","Atenci\u00f3 farmac\u00e8utica","catarates","conjuntivitis","DMAE","farm\u00e0cia comunit\u00e0ria","gent gran","glaucoma","malalties de les parpelles","oftalmologia","patologies oftalmol\u00f2giques","retinopatia diab\u00e8tica","salut ocular"],"articleSection":["M\u00f3n col\u00b7legial"],"inLanguage":"ca","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/","url":"https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/","name":"Formacions COFB: quines s\u00f3n les patologies oftalmol\u00f2giques de m\u00e9s prevalen\u00e7a?","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/#primaryimage"},"thumbnailUrl":"","datePublished":"2017-05-22T10:14:40+00:00","dateModified":"2017-05-22T10:14:40+00:00","description":"Formacions COFB: quines s\u00f3n les patologies oftalmol\u00f2giques de m\u00e9s prevalen\u00e7a?","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Formacions COFB: quines s\u00f3n les patologies oftalmol\u00f2giques de m\u00e9s prevalen\u00e7a?"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"La prevalen\u00e7a elevada de les patologies oftalmol\u00f2giques i les alteracions oculars genera un problema de salut sociosanitari, tant perqu\u00e8 algunes van lligades a l\u2019envelliment de la poblaci\u00f3 com \u00e9s el cas del glaucoma, de les cataractes i de la degeneraci\u00f3 macular associada a l\u2019edat (DMAE), com un problema de cronicitat [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/30230","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=30230"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/30230\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=30230"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=30230"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=30230"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}